Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Flolan

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Abstract Background: This study aims to compare the effectiveness of inhaled prostacyclin or its analoguesversus nitric oxide (NO… 
2019
2019
Background: No previous studies exist examining 2 inhaled epoprostenol formulations in an acute respiratory distress syndrome… 
  • figure 1
  • table 1
  • table 2
2018
2018
Background: No previous studies exist examining two inhaled epoprosternol formulations (Flolan compared with Veletri) in a… 
  • table 1
  • figure 1
  • table 2
  • table 2
  • figure 2
2018
2018
Learning Objectives: Flolan and Veletri are two brand products of epoprostenol which have been administered via the inhalation… 
2015
2015
Inhaled Nitric Oxide (INO) and other inhaled pulmonary vasodilators, like Flolan, have demonstrated positive physiological… 
  • figure 2
  • table 1
2011
2011
Pharmacokinetics (PK) and hemodynamics of two formulations of epoprostenol sodium for injection, epoprostenol with expanded… 
2010
2010
Introduction:  Long‐term intravenous infusion of epoprostenol and treprostinil for treatment of pulmonary arterial hypertension… 
1996
1996
Prospective economic assessments of new pharmaceutical therapies are increasingly being incorporated into phase III clinical… 
1995
1995
Patients (Pts) with primary pulmonary hypertension (PPH) pose a difficult management problem. There are few effective therapies… 
1995
1995
  • Duroux
  • Revue de l'infirmiere
  • 1995
  • Corpus ID: 5465110